Postpartum depression, Neonatal neurodevelopment
Conditions
Interventions
none:None
Sponsors
Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision and Brain Health), Institute of Aging, Key Laboratory of Alzheimer’s Disease of Zhejiang Province, The Second Affiliated Hospital, Wenzhou Medical University, Wenzhou, China.
Eligibility
Sex/Gender
Female
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: (1) Healthy pregnant women with = 37 weeks of gestation (2) Age 18-40 (3) The patient agrees to participate in the project and signs the informed consent
Exclusion criteria
Exclusion criteria: (1) The mother's last menstrual date is not clear (2) Patients with serious pregnancy complications during pregnancy, or patients with serious physical diseases (such as cardiovascular, liver, kidney, gastrointestinal diseases, etc.), infectious diseases and immune system diseases (3) Patients with severe neurological diseases (4) Merging with other mental illness or substance dependence (5) Infants and young children with DIC, anemia, severe infection, bilirubin encephalopathy and other related serious complications during the study could not be followed up (6) Failed to complete the late follow-up scale and infant development screening test scale due to various factors. (7) Failure to sign informed consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| B vitamin concentration;Degree of depression;Degree of neonatal neurodevelopment; | — |
Secondary
| Measure | Time frame |
|---|---|
| Height of newborn; Weight of newborn;Degree of Anxiety;Maternal attachment degree;Sleep quality;Degree of maternal attachment; | — |
Countries
China
Contacts
Public ContactWeihong Song / Zhenlang Lin
Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision and Brain Health), Institute of Aging, Key Laboratory of Alzheimer’s Disease of Zhejiang Province, The Second Affiliated Hospital, Wenzhou Medical University, Wenzhou, China.
Outcome results
None listed